<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> has been suggested as an independent risk factor for the development of <z:hpo ids='HP_0001402'>hepatocellular carcinoma</z:hpo> (<z:mp ids='MP_0003331'>HCC</z:mp>) </plain></SENT>
<SENT sid="1" pm="."><plain>However, the role of Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> on the development of <z:mp ids='MP_0003331'>HCC</z:mp> in the presence of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0012115'>hepatitis</z:hpo> B (CHB) remains inconclusive </plain></SENT>
<SENT sid="2" pm="."><plain>We conducted this hospital-based case-control study to evaluate the roles of Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in <z:mp ids='MP_0003331'>HCC</z:mp> development in patients with CHB </plain></SENT>
<SENT sid="3" pm="."><plain>From January 2004 to December 2008, a total of 6,275 eligible consecutive patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0012115'>hepatitis</z:hpo> B virus (HBV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> were recruited </plain></SENT>
<SENT sid="4" pm="."><plain>A total of 1,105 of them were patients with HBV-related <z:mp ids='MP_0003331'>HCC</z:mp> and 5,170 patients were CHB but without <z:mp ids='MP_0003331'>HCC</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>We used multivariate logistic regression models to investigate the association between Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:mp ids='MP_0003331'>HCC</z:mp> risk </plain></SENT>
<SENT sid="6" pm="."><plain>The prevalence of Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is higher among <z:mp ids='MP_0003331'>HCC</z:mp> patients without <z:hpo ids='HP_0001394'>cirrhosis</z:hpo> than among those with <z:hpo ids='HP_0001394'>cirrhosis</z:hpo> (12.1% vs. 6.7%, p=0.003) </plain></SENT>
<SENT sid="7" pm="."><plain>Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> was associated with a significantly high risk of <z:mp ids='MP_0003331'>HCC</z:mp> in female patients after adjusting for age, family history of <z:mp ids='MP_0003331'>HCC</z:mp>, city of residence, <z:hpo ids='HP_0012115'>hepatitis</z:hpo> B e antigen and <z:hpo ids='HP_0001394'>cirrhosis</z:hpo> with an odds ratio (95% confidence interval, CI) of 1.9 (1.1-3.4) </plain></SENT>
<SENT sid="8" pm="."><plain>Restricted analyses among female patients without <z:hpo ids='HP_0001394'>cirrhosis</z:hpo> indicated that Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> was strongly associated with <z:mp ids='MP_0003331'>HCC</z:mp> risk with adjusted odds ratio (95% CI) of 5.6 (2.2-14.1) </plain></SENT>
<SENT sid="9" pm="."><plain>In conclusion, Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is independently associated with the increased risk of <z:mp ids='MP_0003331'>HCC</z:mp> in female CHB patients </plain></SENT>
<SENT sid="10" pm="."><plain>Female CHB patients with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> are of a high <z:mp ids='MP_0003331'>HCC</z:mp> risk population and should be considered for <z:mp ids='MP_0003331'>HCC</z:mp> close surveillance program </plain></SENT>
</text></document>